Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma
NCT03695055
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
High-risk Aggressive Lymphoma After Auto-HSCT
Interventions
DRUG:
Maintenance therapy post-HSCT
Sponsor
Fujian Medical University